Overview


According to FutureWise analysis the market for absorbable heart stent in 2023 is US$ 359.8 Million, and is expected to reach US$ 906.2 Million by 2031 at a CAGR of 12.20%.

An absorbable heart stent is a highly effective medical tool for treating coronary artery disease (CAD). Its primary function is to provide temporary support to the coronary arteries responsible for supplying the heart muscle with blood. The stent is placed in a narrowed or blocked coronary artery to help restore normal blood flow to the heart. Unlike traditional metal stents, which remain in the body permanently, absorbable stents are made from biodegradable materials that gradually dissolve over time. The stent offers mechanical support to the artery for a few months up to several years. During this time, it aids in keeping the artery open and preventing it from collapsing.

The key advantage of absorbable heart stents is that they eliminate the need for a permanent implant in the body. Once the stent dissolves, there is no foreign material left in the artery, reducing the long-term risks associated with metal stents, such as late stent thrombosis or in-stent restenosis. The introduction of absorbable heart stents represents a significant advancement in the field of interventional cardiology. This approach provides a potentially safer way to treat coronary artery disease. The stent gradually disappears, allowing the artery to resume its natural function, adapt to changes in blood flow, and potentially reduce the need for long-term antiplatelet medications.

FutureWise Market Research has published a report that provides an insightful analysis of Absorbable Heart Stent Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Absorbable Heart Stent Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  •  Abbott Laboratories
  •  Biotronik
  •  REVA Medical, Inc.
  •  Elixir Medical Corporation
  •  Medtronic
  •  KYOTO MEDICAL PLANNING Co., Ltd.
  •  Boston Scientific Corporation
  •  Terumo Medical Corporation
  •  Meril Life Sciences Pvt. Ltd
  •  B. Braun Melsungen AG

(Note: The list of the major players will be updated with the latest market scenario and trends)

The growth and demand for absorbable heart stents are expected to be fueled by several significant factors. It is anticipated that the increase in CAD cases, along with the resulting growth in percutaneous coronary intervention procedures, will lead to market expansion. Moreover, the growing number of patients with chronic diseases, along with strong government initiatives for healthcare reforms, will contribute to the expansion of the global absorbable heart stent market during the forecast period. Furthermore, it is evaluated that the market will receive a positive impact due to the huge patient base and an escalating incidence of coronary artery disease (CAD) and peripheral artery disease (PAD). The rise in the geriatric population and rapid advancements in technology will also act as significant factors driving the growth of the absorbable heart stent market. Furthermore, the increased adoption of these stents by healthcare professionals, regulatory approvals, growing awareness of the advantages associated with absorbable cardiac stents, and a preference for minimally invasive therapies by patients are expected to provide significant growth opportunities for the absorbable heart stent market throughout the forecast period. However, the high cost of absorbable cardiac stents and the potential for product failure and recalls may limit market growth. Additionally, declining costs of stents and complications associated with stent implantation pose challenges to the growth of the absorbable heart stent market. 

By Material

  •  Metal
  •  Polymer

By Application

  •  Coronary Artery Disease
  •  Periphery Artery Disease

By End Use

  •  Hospitals and Clinics
  •  Research and Academic Institutes
  •  Others

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The market for absorbable heart stents has shown significant growth, with North America leading the market due to various factors, including the rise in the number of individuals suffering from long-term medical conditions and the implementation of healthcare reforms by governments. The region has a well-established healthcare infrastructure and advanced medical technologies, which contribute to the adoption of absorbable heart stents. On the other hand, the APAC region is expected to experience substantial growth in the absorbable heart stent market. The expansion can be attributed to the swift progress in healthcare infrastructure in countries like China and India, coupled with a rising prevalence of chronic illnesses, including CVDs. Also, the increasing awareness of advanced treatment options and a notable increase in healthcare expenditure in the region are also contributing factors.

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants
  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth
  •  To provide with an exhaustive analysis on the Absorbable Heart Stent Market By Material, By Application, By End Use and By Region
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  •  To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Absorbable Heart Stent Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Absorbable Heart Stent Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Absorbable Heart Stent Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Absorbable Heart Stent Market, By Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Metal
        2. Polymer

  • 8.   Absorbable Heart Stent Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Coronary Artery Disease
        2. Periphery Artery Disease

  • 9.   Absorbable Heart Stent Market, By End Use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals and Clinics
        2. Research and Academic Institutes
        3. Others

  • 10.   North America Absorbable Heart Stent Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Absorbable Heart Stent Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Absorbable Heart Stent Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Absorbable Heart Stent Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. SOFSERA CORPORATION
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. BERKELEY ADVANCED BIOMATERIALS
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. TAIHEI CHEMICAL INDUSTRIAL CO. LTD.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. SIGMAGRAFT
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. CAM BIOCERAMICS
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Boston Scientific Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Terumo Medical Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Meril Life Sciences Pvt. Ltd
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
         10. B. Braun Melsungen AG
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients